{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:47:39Z","timestamp":1778150859664,"version":"3.51.4"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>\n            Background\u2003Little is known on how sports participation affects bleeding risk in hemophilia. This study aimed to examine associations between sports participation, factor VIII (FVIII) levels and bleeding in persons with hemophilia A.<\/jats:p><jats:p>\n            Methods\u2003In this observational, prospective, single-center study, persons with hemophilia A who regularly participated in sports were followed for 12 months. The associations of patient characteristics, FVIII levels, and type\/frequency of sports participation with bleeding were analyzed by repeated time-to-event modelling.<\/jats:p><jats:p>\n            Results\u2003One hundred and twelve persons (median age: 24 years [interquartile range:16\u201334], 49% severe, 49% on prophylaxis) were included. During follow-up, 70 bleeds of which 20 sports-induced were observed. FVIII levels were inversely correlated with the bleeding hazard; a 50% reduction of the baseline bleeding hazard was observed at FVIII levels of 3.1 and a 90% reduction at 28.0\u2009IU\/dL. The bleeding hazard did not correlate with sports participation. In addition, severe hemophilia, prestudy annual bleeding rate, and presence of arthropathy showed a positive association with the bleeding hazard.<\/jats:p><jats:p>\n            Conclusion\u2003This analysis showed that FVIII levels were an important determinant of the bleeding hazard, but sports participation was not. This observation most likely reflects the presence of adequate FVIII levels during sports participation in our study. Persons with severe hemophilia A exhibited a higher bleeding hazard at a similar FVIII levels than nonsevere, suggesting that the time spent at lower FVIII levels impacts overall bleeding hazard. These data may be used to counsel persons with hemophilia regarding sports participation and the necessity of adequate prophylaxis.<\/jats:p>","DOI":"10.1055\/a-1983-0594","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T23:30:10Z","timestamp":1668900610000},"page":"317-325","source":"Crossref","is-referenced-by-count":13,"title":["Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A"],"prefix":"10.1055","volume":"123","clinical-trial-number":[{"clinical-trial-number":"ntr6769","registry":"10.18810\/dutch-trial-register"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7967-1023","authenticated-orcid":false,"given":"Laura H.","family":"Bukkems","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, Noord-Holland, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-1364","authenticated-orcid":false,"given":"Olav","family":"Versloot","sequence":"additional","affiliation":[{"name":"Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands"},{"name":"Department of Physiotherapy, Institute of Movement Studies, University of Applied Science, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Erasmus University Medical Center - Sophia Children's Hospital Rotterdam, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8240-0865","authenticated-orcid":false,"given":"Siv","family":"J\u00f6nsson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Uppsala University, Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats O.","family":"Karlsson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Uppsala University, Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron A.A.","family":"Math\u00f4t","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, Noord-Holland, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathelijn","family":"Fischer","sequence":"additional","affiliation":[{"name":"Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,12,31]]},"reference":[{"issue":"09","key":"ref1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab prophylaxis in patients who have hemophilia a without inhibitors","volume":"379","author":"J Mahlangu","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00913847.1990.11710175","article-title":"Hemophilia and sports","volume":"18","author":"L G McLain","year":"1990","journal-title":"Phys Sportsmed"},{"issue":"06","key":"ref3","first-page":"324","article-title":"Physical fitness in children with hemophilia","volume":"65","author":"B Koch","year":"1984","journal-title":"Arch Phys Med Rehabil"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00005768-200001000-00009","article-title":"Anaerobic power and muscle strength in young hemophilia patients","volume":"32","author":"B Falk","year":"2000","journal-title":"Med Sci Sports Exerc"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2516.2001.00563.x","article-title":"Proprioception and isometric muscular strength in haemophilic subjects","volume":"7","author":"T Hilberg","year":"2001","journal-title":"Haemophilia"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/ije\/dyr112","article-title":"Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies","volume":"40","author":"G Samitz","year":"2011","journal-title":"Int J Epidemiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(12)61031-9","article-title":"Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy","volume":"380","author":"I M Lee","year":"2012","journal-title":"Lancet"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2516.2009.02096.x","article-title":"Fitness and quality of life in children with haemophilia","volume":"16","author":"C R Broderick","year":"2010","journal-title":"Haemophilia"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2516.2008.01928.x","article-title":"Physical fitness in children with haemophilia and the effect of overweight","volume":"15","author":"D CM Douma-van Riet","year":"2009","journal-title":"Haemophilia"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/hae.14366","article-title":"Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study","volume":"27","author":"O Versloot","year":"2021","journal-title":"Haemophilia"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1542\/peds.2009-0072","article-title":"Athletic participation in severe hemophilia: bleeding and joint outcomes in children on prophylaxis","volume":"124","author":"C Ross","year":"2009","journal-title":"Pediatrics"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2516.2009.01990.x","article-title":"Physical activity participation and bleeding characteristics in young patients with severe haemophilia","volume":"15","author":"R Tiktinsky","year":"2009","journal-title":"Haemophilia"},{"issue":"14","key":"ref13","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.2012.12727","article-title":"Association between physical activity and risk of bleeding in children with hemophilia","volume":"308","author":"C R Broderick","year":"2012","journal-title":"JAMA"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1038\/psp.2013.18","article-title":"A time to event tutorial for pharmacometricians","volume":"2","author":"N Holford","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1023\/A:1020930626404","article-title":"A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic effect of ondansetron","volume":"27","author":"E H Cox","year":"1999","journal-title":"J Pharmacokinet Biopharm"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3324\/haematol.2019.217133","article-title":"Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients","volume":"105","author":"J A Abrantes","year":"2020","journal-title":"Haematologica"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/hae.13977","article-title":"Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project","volume":"26","author":"D M Hajducek","year":"2020","journal-title":"Haemophilia"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.2196\/resprot.6558","article-title":"Development of a Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo): study protocol","volume":"5","author":"A Iorio","year":"2016","journal-title":"JMIR Res Protoc"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.2196\/resprot.6559","article-title":"Data analysis protocol for the development and evaluation of population pharmacokinetic models for incorporation into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo)","volume":"5","author":"A McEneny-King","year":"2016","journal-title":"JMIR Res Protoc"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/psp4.12741","article-title":"An introduction to the full random effects model","volume":"11","author":"G Yngman","year":"2022","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref21","volume-title":"Playing It Safe: Bleeding Disorders, Sports and Exercise","author":"A Anderson","year":"2017"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.21037\/tp.2017.04.07","article-title":"Sports participation recommendations for patients with bleeding disorders","volume":"6","author":"C Howell","year":"2017","journal-title":"Transl Pediatr"},{"issue":"S 06","key":"ref24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2516.2008.01889.x","article-title":"The role of rehabilitation and sports in haemophilia patients with inhibitors","volume":"14","author":"L Heijnen","year":"2008","journal-title":"Haemophilia"},{"issue":"S 77","key":"ref25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/ort.1965.36.suppl-77.01","article-title":"Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B","author":"A Ahlberg","year":"1965","journal-title":"Acta Orthop Scand Suppl"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1538-7836.2008.03270.x","article-title":"Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A","volume":"7","author":"P W Collins","year":"2009","journal-title":"J Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1983-0594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:21:15Z","timestamp":1677802875000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1983-0594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":25,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2023,3,2]]},"published-print":{"date-parts":[[2023,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1983-0594","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,19]]},"published":{"date-parts":[[2022,11,19]]}}}